Zenotech Laboratories Limited

Healthcare · Pharmaceuticals & Biotechnology

BSE: 532039
₹41.83
▼ -0.68 (-1.60%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
49/100
Moderate
Valuation
66/100
Fairly Valued
Momentum
11/100
Bearish

QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹255 Cr
PE (TTM)
Data unavailable.
Price to Book
2.7
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-41.3
Free Cash Flow
₹2 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
-143.75%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
-133.61%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
4.65%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
-356.18%
as of March 31, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
11.08%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
3.40
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
79.71
as of Sept. 30, 2025
Industry median 10.58 (182 companies)
Net Margin
-35.54%
as of March 31, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
-6.26%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
5.70%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
-1.59%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
4.23%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
-1.86%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 5 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (-1.9%)
  • Yes Net cash flow for the latest year is positive

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 5 met
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-1.6%
Low 41.7600 · High 42.5100
1W return
-6.0%
Low 41.0100 · High 44.9700
1M return
-9.6%
Low 41.0100 · High 48.0000
52W return
-41.3%
Low 41.0100 · High 50.0000
Lifetime High ₹171.6000 (July 16, 2007)
Lifetime Low ₹9.9000 (Sept. 16, 2013)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
42.5
10D
43.2
20D
44.4
50D
48.3
100D
53.6
200D
62.1

Delivery and volume

Day avg. delivery
83.8%
Week avg. delivery
78.9%
Month avg. delivery
76.1%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

42.03
Pivot
First resistance42.31
Second resistance42.78
Third resistance43.06
First support41.56
Second support41.28
Third support40.81
Day RSI32.3
Day MFI18.0
Day MACD-1.62
Day MACD signal-1.62

Beta

1M0.41
3M0.44
1Y0.44
3Y0.89

Price change analysis

↓ -9.6%
Over 1 Month
LowHigh
41.0148.00
↓ -41.3%
Over 3 Months
LowHigh
41.0150.00
↓ -41.3%
Over 6 Months
LowHigh
41.0150.00
↓ -41.3%
Over 1 Year
LowHigh
41.0150.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹10 Cr
Net profit (June 30, 2026)
₹— Cr
Basic EPS (June 30, 2026)
₹-0.0700

Ranks #112 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter68.84%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 68.84% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
15 Jul 2009 DEUTSCHE TRUSTEE SERVICES (I) PRIVATE LIMITED Bulk Buy 222,316 107.0500 BSE
8 Nov 2007 RANBAXY LABORATORIES LTD Block Buy 4,000,000 160.0000 BSE
8 Nov 2007 JAYARAM CHIGURUPATI Block Sell 4,000,000 160.0000 BSE
8 Nov 2007 JAYARAM CHIGURUPATI Bulk Sell 7,878,906 160.0000 BSE
8 Nov 2007 RANBAXY LABORATORIES LTD Bulk Buy 7,878,906 160.0000 BSE
9 Dec 2004 SAMBASIVA RAO VEMURI Bulk Sell 40,000 97.0500 BSE
20 Sep 2004 PIVOTAL SEC.PVT.LTD. Bulk Sell 35,900 69.2900 BSE
20 Sep 2004 REKHA JHUNJHUNWALA Bulk Buy 36,000 68.0100 BSE
13 May 2004 Paharpur Cooling Towers L Bulk Buy 30,000 63.7500 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Sunline Tubes Ltd. to Sunline Technologies Ltd.

All corporate actions →

Corporate Announcements

All 1 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
25 Sep 2026 AGM/EGM Zenotech Laboratories Ltd - 532039 - Shareholder Meeting / Postal Ballot-Outcome of AGM

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (79.7x)

Weaknesses

  • Low Return on Equity (-1.9%)
  • Thin net profit margin (-35.5%)
  • Declining profit YoY (-356.2%)

Opportunities

Data unavailable.

Threats

  • Down 41.3% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Zenotech Laboratories Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.